FDA approved 46 new (“novel”) drugs in 2025 that had not been approved or marketed in the United States.

Mark S. Johnson, PharmD, MACE, BCPS

In 2024, the March of Dimes Report Card, an annual report that grades states on maternal and infant health, detailed information on maternity care within the United States. The report indicated approximately 36% of the country lies within a maternity care desert.¹

Karen L. Kier, PhD, MSc, RPh, BCPS, BCACP, CTTS, FASHP, FCCP

During one of my infectious disease APPE rotations at Dayton VA Medical Center in 2022, I was assigned to an experience that would ultimately reshape how I viewed the pharmacist’s role in clinical decision making.

Ayobomi Adefioye, PharmD, MBA, advanced education fellow, APhA, Washington, DC

This past year was a pivotal time for pharmacy; 2025 was marked by both emerging challenges and groundbreaking opportunities to elevate pharmacist-provided patient care.

This year has proven to be a tumultuous time for vaccine recommendations, and perhaps for the first time, national professional medical associations such as the American Academy of Pediatrics (AAP), the American Academy of Family Physicians (AAFP), the American College of Obstetricians and Gynecologists (ACOG), and the Infectious Disease Society of America (IDSA) have published guidelines that depart from those of ACIP and CDC.

Michelle D. Fiscus, MD, FAAP